What's new in neuro-oncology? Recent advances in medulloblastoma.
about
Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.Detection of drug-induced cellular changes using confocal Raman spectroscopy on patterned single-cell biosensors.Medulloblastoma in childhood-King Edward Memorial hospital surgical experience and review: Comparative analysis of the case series of 365 patientsTreatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine.DJ-1 is activated in medulloblastoma and is associated with cell proliferation and differentiationSonic hedgehog-induced histone deacetylase activation is required for cerebellar granule precursor hyperplasia in medulloblastoma.Mouse models of childhood cancer of the nervous systemUsing plasma topotecan pharmacokinetics to estimate topotecan exposure in cerebrospinal fluid of children with medulloblastoma.Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastomaThe micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.Clinical management of medulloblastoma in adults.Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variablesSignaling pathway and molecular subgroups of medulloblastoma.Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials.Effect of Temporal Changes in Therapeutic Exposure on Self-reported Health Status in Childhood Cancer Survivors.SHH inhibitors for the treatment of medulloblastoma.The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma.PCDH10 is a candidate tumour suppressor gene in medulloblastoma.Intracellular distribution of beta-catenin in human medulloblastoma cell lines with different degree of neuronal differentiation.Expression and clinical relevance of SPOPL in medulloblastoma.Bmi1 is required for Hedgehog pathway-driven medulloblastoma expansion.Differential proliferative index of cancer stem-like cells in primary and recurrent medulloblastoma in human.Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior.Immunohistochemical expression of markers Ki-67, neun, synaptophysin, p53 and HER2 in medulloblastoma and its correlation with clinicopathological parameters.Robust infectivity and replication of Delta-24 adenovirus induce cell death in human medulloblastoma.Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma.Shared molecular targets in pediatric gliomas and ependymomas.
P2860
Q33479538-A7E92BCF-02B2-48E8-AEA4-C8BE89D098E4Q33987918-3D1274F6-6BA7-4D1F-A36C-45E804FFF853Q34231046-DA5514D6-BCD4-400C-8654-E013A1DB7661Q34470472-B1536E8E-6309-415A-8104-C3192F6D34BDQ34895825-4ABBAB37-2DC3-480E-8DB7-66ABFDFD6917Q34949592-EAFBF50D-5C07-42CD-88B4-8A8E4F86D1CEQ35786003-65130481-6604-4F4D-B6B7-929F54C88405Q35800620-23764141-99CE-47D7-AF5C-B4C6BB001EBBQ35845219-E21BAB4B-20B4-455B-ADC0-5EC4BA765B61Q35914487-CA5EE4F5-8D24-4791-8B6D-58FAC18D3985Q35918445-C8DFB20E-D2FC-4793-ADAA-12BA79F0F1ADQ36476670-9D70FC42-7F17-469F-BE2C-F3F6C666D1AFQ36956174-B8AF9CBB-DEE3-4100-9EB0-3036EDB88804Q37284365-861A0447-725A-4C92-8754-734F198E4EF6Q37564205-AF1446DD-CBD2-4D23-8CDB-F06D8BD61E77Q37588564-BF1B2C15-BE1D-4FA2-B993-201D204797E2Q38509205-553E2BA0-8037-43EB-B4D2-AE9BF0A8010DQ39061338-FD6A7834-1AEC-4A33-8041-AA944DE1EB3BQ39539408-BFE2C90F-D145-44F3-BE32-FD3B18221469Q40141888-AFC6FABC-15F2-4739-8761-69643FEE87D5Q41612807-9EAF5CFB-07F3-43DB-9763-3783A870F8E8Q41664046-714FEEE8-A746-40FE-8287-B167F9B8DF10Q46033613-56403DFA-5ED9-44A4-9C4B-543FE135BBD3Q48227672-4709F81B-0BBF-44C8-B8AE-5D55769F9434Q49056530-8033FAED-6DF9-4949-A671-A8B3DDA3F280Q50794581-EA9041A6-CE8C-4FAA-9100-B33834DE441BQ51894912-38040795-56D8-4CF0-9AB0-04BB9524AEA6Q55463435-249A9BA6-22C0-4689-97AC-E3D76CA2BA05
P2860
What's new in neuro-oncology? Recent advances in medulloblastoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
What's new in neuro-oncology? Recent advances in medulloblastoma.
@ast
What's new in neuro-oncology? Recent advances in medulloblastoma.
@en
type
label
What's new in neuro-oncology? Recent advances in medulloblastoma.
@ast
What's new in neuro-oncology? Recent advances in medulloblastoma.
@en
prefLabel
What's new in neuro-oncology? Recent advances in medulloblastoma.
@ast
What's new in neuro-oncology? Recent advances in medulloblastoma.
@en
P2093
P1476
What's new in neuro-oncology? Recent advances in medulloblastoma.
@en
P2093
Amar Gajjar
David W Ellison
Richard J Gilbertson
Steven C Clifford
P356
10.1016/S1090-3798(03)00014-X
P577
2003-01-01T00:00:00Z